Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The study is carried out to evaluate the safety, tolerability and pharmacokinetics of
AeroVanc inhalation powder in healthy volunteers, and in patients with cystic fibrosis.